Journal of Jilin University(Medicine Edition) ›› 2024, Vol. 50 ›› Issue (5): 1305-1312.doi: 10.13481/j.1671-587X.20240514

• Research in basic medicine • Previous Articles    

Effect of silencing CDC20 on proliferation and cell cycle of endometrial cancer cells by inhibiting Wnt/β-catenin signaling pathway

Chunjing LIU,Yujie YANG,Wei ZHAO,Lijing LIU,Na WANG()   

  1. Department of Gynecology,Third Affiliated Hospital,Qiqihar Medical College,Qiqihar 161000,China
  • Received:2023-11-13 Online:2024-09-28 Published:2024-10-28
  • Contact: Na WANG E-mail:liuchunjing126@126.com

Abstract:

Objective To discuss the effect of cell division cycle protein 20 (CDC20) on the proliferation and cell cycle of endometrial carcinoma (EC) cells, and to clarify its mechanism. Methods Real-time fluorescence quantitative PCR(RT-qPCR) and Western blotting methods were used to detect the expression levels of CDC20 mRNA and protein in human endometrial stromal T-HESC cell and EC cells (KLE, RL95-2, ZJB-ENC1, and ECC-1 cells). The RL95-2 cells were selected for the subsequent experiments. CDC20 shRNA interference lentivirus was transfected into the RL95-2 cells and the cells were divided into control group, sh-NC group (infected with negative control lentivirus), sh-CDC20 group (infected with CDC20 shRNA interference lentivirus), sh-NC+SM04690 group (infected with negative control lentivirus followed by treatment with 64 nmol·L?1 Wnt/β-catenin signaling pathway inhibitor SM04690 for 48 h), and sh-CDC20+SM04690 group (infected with CDC20 shRNA interference lentivirus followed by treatment with 64 nmol·L?1 SM04690 for 48 h). RT-qPCR and Western blotting methods were used to detect the expression levels of CDC20 mRNA and proteins in the cells in various groups; CCK-8 method was used to detect the proliferation activities of the RL95-2 cells in various groups; BrdU assay was used to detect the percentages of BrdU positive cells in various groups; flow cytometry was used to detect the percentages of the cells at G2/M stage in various groups; Western blotting method was used to detect the expression levels of β-catenin, oncogene c-Myc, and cyclin D1 proteins in the cells in various groups. Results Compared with T-HESC cells, the expression levels of CDC20 mRNA and protein in the KLE, RL95-2, ZJB-ENC1, and ECC-1 cells were significantly increased(P<0.05), and the highest expression levels of CDC20 mRNA and protein were observed in RL95-2 cells. Compared with sh-NC group, the proliferation activities and percentages of the BrdU positive cells in sh-CDC20 group and sh-NC+SM04690 group were significantly decreased (P<0.05), the percentages of the cells at G2/M phase were significantly increased (P<0.05), and the expression levels of β-catenin, c-Myc, and cyclin D1 proteins were significantly decreased (P<0.05). Compared with sh-CDC20 group, the proliferation activity and percentage of BrdU positive cells in sh-CDC20+SM04690 group were significantly decreased (P<0.05), the percentage of the cells at G2/M phase was significantly increased (P<0.05), and the expression levels of β-catenin, c-Myc, and cyclin D1 proteins in the cells were significantly decreased (P<0.05). Conclusion CDC20 is highly expressed in the EC cells. Silencing CDC20 may inhibit the cell proliferation by inducing G2/M phase arrest in the RL95-2 cells through the regulation of Wnt/β-catenin signal transduction.KEYWODS Endometrial cancer; Cell division cycle protein 20; Cell cycle; Cell proliferation; Wnt/β-catenin signaling pathway

CLC Number: 

  • R737.33